Innovative Smartphone Application for Quitting Smoking among Seriously Mentally I

用于认真戒烟的创新智能手机应用程序 I

基本信息

  • 批准号:
    8677529
  • 负责人:
  • 金额:
    $ 17.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-07-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long term goal of this Pathway to Independence Award (PIA) is to develop a program of research focused on increasing the effectiveness and reach of smoking cessation interventions for adults with serious mental illness (SMI) using mobile health technology. This long term goal will be achieved via a 5-year training and research plan that will launch Dr. Roger Vilardaga's independent program of research and academic career. The career objectives of this award are to: (1) become an expert in the science of behavioral smoking cessation interventions; (2) master the development, testing and implementation of mobile health interventions; (3) become an expert in the implementation of clinical trials in people with SMI. These career objectives will be achieved via formal coursework, trainings, seminars, national conferences, mentorship and research experience. The knowledge derived from this training plan will equip the PI to pursue the following aims. The first aim, guided by an expert panel, is to adapt an existing Acceptance and Commitment Therapy smartphone application for smoking cessation (SmartQuit) to people with SMI, and develop a smartphone coaching guide for staff. The second aim is to conduct iterative usability testing of the resulting app (SmartQuit+) and coaching guide in a sample of 10 people with SMI. Finally, the third aim is to conduct a two-arm feasibility randomized trial that compares SmartQuit+ to an app based on best-practice smoking cessation guidelines (NCI QuitPal) in a sample of 90 people with SMI from a community-based setting. Both arms will include a low cost pharmacological intervention (nicotine replacement therapy). The primary feasibility outcomes in this trial (e.g., recruitment and retention rates) will determine a reliable methodological approach to conduct a fully-powered R01 trial. Dr. Jonathan Bricker will serve as primary mentor on this PIA, providing expertise in smoking cessation, ACT applied to smoking cessation, and mobile health interventions. The mentoring and consulting team of experts in SMI, smoking cessation, computer science and methods/statistics (Drs. Ries, Ziedonis, Saxon, Kientz and Atkins), will ensure that the PI receives the necessary support to successfully complete the proposed research. The training activities will take place at the University of Washington and the Fred Hutchinson Cancer Research Center in Seattle, two cutting-edge research institutions that will provide an excellent environment for completion of the PI's objectives. This study meets NIDA's major programmatic priorities of using innovative technologies and integrating behavioral and pharmacological interventions to improve substance use treatment and outcomes (NOT-DA-10-019). The study addresses a serious problem - high smoking rates in people with SMI-, and it proposes the delivery of a promising behavioral intervention for smoking cessation in a "real-world" setting using a wider reaching technology. This PIA will forge the PI's pathway to independence by laying the foundation for a career in mobile health interventions for smoking cessation in people with SMI.
描述(由申请人提供):该独立之路奖(PIA)的长期目标是开发一个研究项目,重点关注使用移动健康技术提高患有严重精神疾病(SMI)的成年人戒烟干预的有效性和覆盖面。这一长期目标将通过一项为期5年的培训和研究计划来实现,该计划将启动罗杰·维拉达加博士的独立研究和学术生涯计划。本奖项的职业目标是:(1)成为行为戒烟干预科学方面的专家;(2)掌握流动卫生干预措施的开发、测试和实施;(3)成为实施重度精神障碍患者临床试验的专家。这些职业目标将通过正式课程、培训、研讨会、全国会议、指导和研究经验来实现。从这个培训计划中获得的知识将装备PI追求以下目标。在专家小组的指导下,第一个目标是将现有的接受和承诺治疗智能手机戒烟应用程序(SmartQuit)应用于重度精神障碍患者,并为员工开发一份智能手机指导指南。第二个目标是在10名重度精神障碍患者的样本中对最终的应用程序(SmartQuit+)和指导指南进行迭代可用性测试。最后,第三个目标是进行一项两组可行性随机试验,将SmartQuit+与基于最佳戒烟实践指南(NCI QuitPal)的应用程序进行比较,样本来自社区环境中的90名重度精神障碍患者。两组将包括低成本的药理学干预(尼古丁替代疗法)。该试验的主要可行性结果(例如,招募和保留率)将确定进行全动力R01试验的可靠方法。Jonathan Bricker博士将担任这一PIA的主要导师,提供有关戒烟、适用于戒烟的ACT和流动卫生干预措施方面的专门知识。SMI、戒烟、计算机科学和方法/统计方面的专家指导和咨询团队(dr。Ries, Ziedonis, Saxon, Kientz和Atkins)将确保PI获得必要的支持,以成功完成拟议的研究。培训活动将在华盛顿大学和西雅图的弗雷德·哈钦森癌症研究中心进行,这两家前沿研究机构将为完成PI的目标提供良好的环境。该研究符合NIDA的主要规划优先事项,即使用创新技术,整合行为和药理学干预,以改善药物使用治疗和结果(NOT-DA-10-019)。这项研究解决了一个严重的问题——重度精神障碍患者的高吸烟率,并提出了一种有希望的行为干预方法,可以在“现实世界”的环境中使用更广泛的技术来戒烟。通过为重度精神分裂症患者戒烟的流动卫生干预工作奠定基础,该项目将为重度精神分裂症患者的独立之路奠定基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Roger Vilardaga其他文献

Roger Vilardaga的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Roger Vilardaga', 18)}}的其他基金

Increasing the health equity and population-level impact of a digital therapeutic for smokers with psychiatric illness
提高数字疗法对患有精神疾病的吸烟者的健康公平性和人口影响
  • 批准号:
    10597126
  • 财政年份:
    2022
  • 资助金额:
    $ 17.22万
  • 项目类别:
Increasing the health equity and population-level impact of a digital therapeutic for smokers with psychiatric illness
提高数字疗法对患有精神疾病的吸烟者的健康公平性和人口影响
  • 批准号:
    10457176
  • 财政年份:
    2022
  • 资助金额:
    $ 17.22万
  • 项目类别:
Randomized Controlled Trial of a Novel Smoking Cessation Application Tailored to Individuals with Serious Mental Illness
针对严重精神疾病患者的新型戒烟应用程序的随机对照试验
  • 批准号:
    10538646
  • 财政年份:
    2020
  • 资助金额:
    $ 17.22万
  • 项目类别:
Randomized Controlled Trial of a Novel Smoking Cessation Application Tailored to Individuals with Serious Mental Illness
针对严重精神疾病患者的新型戒烟应用程序的随机对照试验
  • 批准号:
    10318201
  • 财政年份:
    2020
  • 资助金额:
    $ 17.22万
  • 项目类别:
An Administrative Supplement to Increase the Recruitment Rates of R01 DA047301 a Pivotal Trial of a Novel Digital Therapeutic for Smoking Cessation in Psychiatric Populations
提高 R01 DA047301 招募率的行政补充 精神病人群戒烟新型数字疗法的关键试验
  • 批准号:
    10818811
  • 财政年份:
    2020
  • 资助金额:
    $ 17.22万
  • 项目类别:
Randomized Controlled Trial of a Novel Smoking Cessation Application Tailored to Individuals with Serious Mental Illness
针对严重精神疾病患者的新型戒烟应用程序的随机对照试验
  • 批准号:
    9885332
  • 财政年份:
    2020
  • 资助金额:
    $ 17.22万
  • 项目类别:
Early-phase Studies of a Tailored Evidence-Based Smoking Cessation mHealth App for Persons Living with HIV
针对艾滋病毒感染者量身定制的循证戒烟 mHealth 应用程序的早期研究
  • 批准号:
    10016254
  • 财政年份:
    2019
  • 资助金额:
    $ 17.22万
  • 项目类别:
Innovative Smartphone Application for Quitting Smoking among Seriously Mentally III
用于戒烟的创新智能手机应用程序 III
  • 批准号:
    9326973
  • 财政年份:
    2016
  • 资助金额:
    $ 17.22万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 17.22万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.22万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 17.22万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.22万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 17.22万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.22万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 17.22万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 17.22万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 17.22万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.22万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了